Daily Cosmetic Research Analysis
Three impactful studies intersect cosmetic and aesthetic medicine: a large in-silico analysis suggests GLP-1 receptor agonists may shorten botulinum toxin A durability across neurologic and aesthetic uses; a blinded evaluation benchmarks large language models for aesthetic plastic surgery tasks; and a forensic autopsy series identifies risk patterns underlying liposuction-related fatalities. Together, they inform treatment planning, digital tool selection, and safety protocols.
Summary
Three impactful studies intersect cosmetic and aesthetic medicine: a large in-silico analysis suggests GLP-1 receptor agonists may shorten botulinum toxin A durability across neurologic and aesthetic uses; a blinded evaluation benchmarks large language models for aesthetic plastic surgery tasks; and a forensic autopsy series identifies risk patterns underlying liposuction-related fatalities. Together, they inform treatment planning, digital tool selection, and safety protocols.
Research Themes
- Drug–procedure interaction affecting aesthetic outcomes
- AI benchmarking for aesthetic plastic surgery
- Patient safety and risk factors in cosmetic surgery
Selected Articles
1. Computational modelling the impact of GLP-1 receptor agonists on botulinum toxin A: Evidence for reduced treatment durability across neurologic and aesthetic indications.
A transparent microsimulation of 25,000 virtual subjects suggests GLP-1 receptor agonists shorten BoNT-A durability in chronic migraine and masseter treatment by 1.4–3.9 weeks, driven mainly by synaptic modulation and body composition changes. Findings are hypothesis-generating and require experimental and clinical validation before changing dosing intervals.
Impact: This work introduces a mechanistically parameterized model linking GLP-1 signaling to BoNT-A recovery, with direct relevance to two high-prevalence indications in neurology and aesthetics. It raises a clinically important hypothesis that could influence treatment scheduling and counseling.
Clinical Implications: Clinicians should be aware that patients on GLP-1 RAs may experience earlier BoNT-A wear-off; consider closer follow-up and documentation of duration. No immediate dosing changes are warranted until validated in cellular and prospective clinical studies.
Key Findings
- BoNT-A mean duration decreased in chronic migraine from 14.0 ± 2.3 weeks (control) to 11.8–12.6 weeks under GLP-1 exposure (all p < 0.001; HR 1.54–1.95).
- BoNT-A mean duration in masseter prominence decreased from 20.1 ± 2.9 weeks to 16.2–17.3 weeks (HR 1.72–2.08).
- Agent hierarchy for wear-off: tirzepatide > liraglutide > dulaglutide > semaglutide.
- Sensitivity analysis: 55% synaptic modulation, 30% lean-mass decline, 15% metabolic variability contributions.
Methodological Strengths
- Transparent, parameterized microsimulation with mechanistic domains (synaptic, diffusion, metabolic).
- Large virtual cohort (n = 25,000) spanning neurologic and aesthetic indications with sensitivity analyses.
Limitations
- Entirely computational with no in vitro or clinical validation.
- Assumptions about cAMP-PKA–SNAP-25 modulation and diffusion kinetics may not generalize to all clinical contexts.
Future Directions: Validate predictions in neuronal culture and animal models; conduct prospective cohorts to quantify BoNT-A duration in patients initiating GLP-1 RAs; explore dose or interval adjustments if effects are confirmed.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed metabolic and aesthetic medicine, yet their potential influence on botulinum toxin type A (BoNT-A) pharmacodynamics remains unexplored. Using the AesthetiSIM™ microsimulation platform, a transparent, parameterized in-silico model was developed to estimate whether GLP-1-related changes in metabolism and neuromuscular recovery could alter toxin durability. Twenty-five thousand virtual patients were generated, representing two domains of BoNT-A use: chronic migraine (n = 20,000) and masseter prominence (n = 5000). Virtual subjects were randomly assigned to semaglutide, tirzepatide, liraglutide, dulaglutide, or control conditions, and simulated over one year under standardized 100-unit BoNT-A dosing. The framework incorporated three mechanistic domains-synaptic modulation via cAMP-PKA-mediated SNAP-25 phosphorylation, lean-mass reduction affecting diffusion kinetics, and systemic metabolic variability reflecting diabetic or rapid-weight-loss phenotypes. In chronic migraine, mean BoNT-A duration declined from 14.0 ± 2.3 weeks in controls to 12.6, 12.5, 12.2, and 11.8 weeks across GLP-1 exposures (all p < 0.001; hazard ratio range 1.54-1.95). In masseter prominence, mean duration decreased from 20.1 ± 2.9 weeks to 17.3, 17.0, 16.7, and 16.2 weeks, with hazard ratios 1.72-2.08. Early wear-off and uncovered symptomatic periods rose proportionally across agents, with the hierarchy tirzepatide > liraglutide > dulaglutide > semaglutide. Sensitivity analyses indicated that approximately 55 % of the reduction in duration was attributable to synaptic modulation, 30 % to lean-mass decline, and 15 % to metabolic variability. These findings suggest a biologically plausible interaction between GLP-1 signalling and BoNT-A recovery dynamics. The results are exploratory and derive entirely from computational modelling rather than clinical observation. Experimental validation-such as neuronal culture assays or prospective patient cohorts-is required before any modification of treatment intervals or dosing practices can be considered.
2. Evaluating the Performance of Different Large Language Models on Plastic and Aesthetic Surgery: A Cross-Sectional Blinded Study.
In a blinded expert assessment of 125 aesthetic plastic surgery tasks, DeepSeek R1 led in comprehensiveness, readability, and humanistic care, while GPT-4o showed strong scientific accuracy and safety. Claude 3.5 trailed in trustworthiness and comprehensiveness, indicating model selection should be task-specific and supervised.
Impact: Provides an early, blinded benchmark for LLMs in aesthetic plastic surgery, directly informing safe clinical deployment and model choice for education, counseling, and decision support.
Clinical Implications: Use LLMs as adjuncts with human oversight; select models based on task (e.g., DeepSeek R1 for comprehensive counseling drafts, GPT-4o where accuracy/safety are paramount). Avoid unsupervised recommendations for procedural decisions.
Key Findings
- DeepSeek R1 outperformed in comprehensiveness (P = 0.04), readability (P < 0.001), and humanistic care (P < 0.001).
- All models showed reasonable safety/ethical standards, but Claude 3.5 scored lower in trustworthiness and comprehensiveness.
- Task set spanned MCQs, clinical cases, guideline adherence, and patient consultations, reflecting real-world aesthetic plastic surgery needs.
Methodological Strengths
- Blinded expert evaluation with predefined criteria across multiple clinical task types.
- Head-to-head comparison of three state-of-the-art models with statistical testing of differences.
Limitations
- No patient-level outcomes; performance assessed on questions and scenarios only.
- Rapid model updates may limit generalizability; 125-item set may not capture full clinical complexity.
Future Directions: Evaluate LLMs prospectively in clinical workflows (documentation drafts, consent aid) with safety guardrails; expand benchmarks to image-based tasks and multilingual contexts.
BACKGROUND: Large language models (LLMs) have demonstrated potential in various medical fields. However, their application in aesthetic plastic surgery remains largely unexplored, particularly in clinical decision support and patient consultations. Given plastic surgery integrates medical knowledge, aesthetic judgment, and doctor patient communication, a systematic evaluation of LLMs performance is needed. OBJECTIVES: This study aims to assess the capabilities of three widely used LLMs-GPT-4o (OpenAI), DeepSeek R1 (DeepSeek), and Claude 3.5 (Anthropic)-in aesthetic plastic surgery including facial aesthetics, body contouring, and nonsurgical interventions, aiming to provide evidence-based recommendations for model selection across different clinical contexts and to inform future improvements in the design and optimization of domain-specific language models. METHODS: A total of 125 questions were designed, covering multiple-choice examinations, clinical case analysis, expert guideline adherence, and patient consultation scenarios. Responses from each model were evaluated by three blinded plastic surgery experts based on predefined criteria, including accuracy, comprehensiveness, readability, humanistic care, and ethical considerations. RESULTS: DeepSeek R1 demonstrated performance that was superior to or at least comparable to GPT-4o and Claude 3.5 in multiple aspects, particularly in comprehensiveness (P = 0.04), readability (P < 0.001), and humanistic care (P < 0.001). While all models maintained reasonable safety and ethical standards, Claude 3.5 showed lower scores in trustworthiness and comprehensiveness, limiting its reliability in clinical decision support. CONCLUSIONS: Among the three evaluated LLMs, DeepSeek R1 excelled in comprehensiveness, readability, and humanistic care; GPT-4o performed well in scientific accuracy and safety, while Claude 3.5 showed relative strengths in logical coherence. NO LEVEL ASSIGNED: This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
3. Liposuction associated fatalities in Istanbul from a forensic perspective: An autopsy study.
A retrospective autopsy series of 35 liposuction-related fatalities identified high BMI, multiple concurrent procedures, and gluteal fat transfer as dominant risk factors. The findings support stricter preoperative risk stratification, avoidance of combined high-risk procedures, and intensified postoperative monitoring.
Impact: Provides rare, detailed forensic evidence on lethal complications in cosmetic surgery, directly informing patient selection, procedural planning, and safety standards.
Clinical Implications: Implement rigorous preoperative screening (BMI thresholds, comorbidity assessment), avoid combining high-risk procedures such as gluteal fat transfer with extensive liposuction, and ensure postoperative surveillance with early detection of fat embolism and hemorrhage.
Key Findings
- All fatalities were female; mean age 41.7 ± 9.5 years and mean BMI 29.5 ± 3.7 kg/m².
- High BMI, multiple concurrent procedures, and gluteal fat transfer emerged as major risk factors.
- Systematic autopsy and histopathology characterized patterns of lethal complications to guide prevention.
Methodological Strengths
- Comprehensive forensic workflow including autopsy, histopathology, and toxicology.
- Consecutive cases from a national forensic center over a multi-year period.
Limitations
- Retrospective design without denominator data; incidence rates cannot be estimated.
- Limited operative and perioperative detail may restrict causal inference and risk quantification.
Future Directions: Establish multicenter registries capturing denominator and perioperative variables; develop evidence-based safety checklists and risk scores for cosmetic procedures, especially gluteal fat grafting.
BACKGROUND: Liposuction remains one of the most commonly performed cosmetic surgical procedures worldwide, yet fatal complications continue to occur despite advances in surgical techniques. This study aims to conduct forensic pathological analysis of liposuction-related deaths to identify specific complications, underlying causes, and patterns of fatal outcomes. METHODS: This retrospective study analyzed 35 fatal cases following liposuction procedures autopsied at the Council of Forensic Medicine, Turkey, between January 2022 and December 2024. Autopsy findings, histopathological examinations, demographic characteristics, and toxicological results were systematically evaluated. RESULTS: All cases were female with a mean age of 41.7 ± 9.5 years and mean BMI of 29.5 ± 3.7 kg/m CONCLUSION: Fatal liposuction complications have multifactorial etiology, with high BMI, multiple procedures, and gluteal fat transfer representing major risk factors. Comprehensive preoperative assessment, enhanced safety protocols, and close postoperative monitoring are essential for mortality reduction.